Evidence map›Paper›PMID 38923847›Full record

ArticleCancer medicine2024

An explainable machine learning model to solid adnexal masses diagnosis based on clinical data and qualitative ultrasound indicators.

Annarita Fanizzi, Francesca Arezzo, Gennaro Cormio, Maria Colomba Comes, Gerardo Cazzato, Luca Boldrini, Samantha Bove, Michele Bollino, Anila Kardhashi, Erica Silvestris and 6 more

Abstract read
In one paragraph

Article in Cancer medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Annarita FanizziLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.ORCID 0000-0002-2729-9896
Francesca ArezzoGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Gennaro CormioGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Maria Colomba ComesLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Gerardo CazzatoSection of Molecular Pathology, Department of Emergency and Organ Transplantation, University of Bari "Aldo Moro", Bari, Italy.
Luca BoldriniFondazione Policlinico Universitario "A. Gemelli" IRCCS, Italy.
Samantha BoveLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Michele BollinoDepartment of Obstetrics and Gynecology, Division of Gynecologic oncology, Skåne University Hospital and Lund University, Faculty of Medicine, Clinical Sciences, Lund, Sweden.
Anila KardhashiGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Erica SilvestrisGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Pietro QuartoGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele MongelliDepartment of Precision and Regenerative Medicine - Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
Emanuele NaglieriMedical Oncology Unit, IRCCS, Istituto Tumori Giovanni Paolo II, Bari, Italy.
Rahel SignorileLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Vera LoizziGynecologic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Raffaella MassafraLaboratorio Biostatistica e Bioinformatica, I.R.C.C.S. Istituto Tumori 'Giovanni Paolo II', Bari, Italy.

Funding

Ministero della Salute 5 per 1000
6 · The paper itself

Abstract

backgroundAccurate characterization of newly diagnosed a solid adnexal lesion is a key step in defining the most appropriate therapeutic approach. Despite guidance from the International Ovarian Tumor Analyzes Panel, the evaluation of these lesions can be challenging. Recent studies have demonstrated how machine learning techniques can be applied to clinical data to solve this diagnostic problem. However, ML models can often consider as black-boxes due to the difficulty of understanding the decision-making process used by the algorithm to obtain a specific result.

aimsFor this purpose, we propose an Explainable Artificial Intelligence model trained on clinical characteristics and qualitative ultrasound indicators to predict solid adnexal masses diagnosis. MATERIALS &

methodsSince the diagnostic task was a three-class problem (benign tumor, invasive cancer, or ovarian metastasis), we proposed a waterfall classification model: a first model was trained and validated to discriminate benign versus malignant, a second model was trained to distinguish nonmetastatic versus metastatic malignant lesion which occurs when a patient is predicted to be malignant by the first model. Firstly, a stepwise feature selection procedure was implemented. The classification performances were validated on Leave One Out scheme.

resultsThe accuracy of the three-class model reaches an overall accuracy of 86.36%, and the precision per-class of the benign, nonmetastatic malignant, and metastatic malignant classes were 86.96%, 87.27%, and 77.78%, respectively. DISCUSSION: SHapley Additive exPlanations were performed to visually show how the machine learning model made a specific decision. For each patient, the SHAP values expressed how each characteristic contributed to the classification result. Such information represents an added value for the clinical usability of a diagnostic system.

conclusionsThis is the first work that attempts to design an explainable machine-learning tool for the histological diagnosis of solid masses of the ovary.

Indexed as

Adnexal DiseasesMachine LearningOvarian NeoplasmsUltrasonographyAdultAgedAlgorithmsDiagnosis, DifferentialFemaleHumansMiddle Agedgynecological ultrasoundmachine learningovarian cancerprecision medicinesolid adnexal masses

Identifiers

PMID38923847
PMCPMC11196372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.